May 19-20, 2008

Benton Convention Center
Winston-Salem, NC

Biotech 2008 Conference

Speakers

Hear life science industry leaders discuss the latest biotechnology developments, trends and issues in the sector and the region's global impact on life sciences.

Featured Speakers

Frederick Frank
Vice Chairman and a Director
Lehman Brothers Inc.

Frederick FrankFrederick Frank is Vice Chairman and a Director of Lehman Brothers Inc. Before joining Lehman Brothers as a Partner in October, 1969, Mr. Frank was co-director of research, as well as Vice President and Director, of Smith, Barney & Co. Incorporated. He is a Chartered Financial Analyst, a member of The New York Society of Security Analysts and a past president of the Chemical Processing Industry Analysts.

Born in Salt Lake City on May 31, 1932, Mr. Frank graduated from the Hotchkiss School in 1950 and from Yale University in 1954. He then spent two years in the Army, most of the time stationed with Supreme Headquarters Allied Powers Europe (SHAPE) in Paris. After release from service, he attended Stanford Graduate School of Business Administration. He received his MBA from Stanford in 1958 and began his Wall Street career that year.  He also has a CFA Degree.

In addition to serving the as the Chairman of the Board of Epix Pharmaceuticals, Mr. Frank is a Director of Landec Corporation; Institute for Systems Biology; and Pharmaceutical Product Development, Inc.  He is Chairman of the National Genetics Foundation; a past director of the Salk Institute; a member of the Yale School of Organization and Management Advisory Board, a member of the Pharmaceutical Executive Magazine advisory board and The Journal of Life Sciences, Chairman of the Board of The Irvington Institute for Immunological Research, a member of the Advisory Board of The Harvard School of Public Health and also the John's Hopkin's Bloomberg School of Public Health, and he serves on the Advisory Board of the Massachusetts Institute of Technology Center for Biomedical Innovation.  He is past President of the Board of the The Hotchkiss School, and currently serves as a Director Emeritus.

Mr. Frank was honored for Outstanding Contributions in the Field of Immunology in 1998 by the Irvington Institute for Immunological Research, and, in 1997, he received the Biotech Meeting at Laguna Niguel Hall of Fame Award for Special Recognition for an Individual.  He received The Albert Einstein Award from the Weizmann Institute of Science in 2004, the 2006 Gilda’s Club of New York City Visionary Award and was selected The Top 100 Living Contributors to Biotechnology by Reed Elsevier and in 2007 he received the Award for Excellence from the American Liver Foundation.

Mr. Frank has provided investment banking services to an extensive number of companies in the pharmaceutical, biotechnology, healthcare service providers, medical device and nutraceutical industries, and has been involved in hundreds of financings and merger and acquisition transactions in the health care field.


John Maraganore, Ph.D.
President and Chief Executive Officer
Alnylam Pharmaceuticals, Inc.

John Maraganore, Ph.D.John Maraganore joined Alnylam in December 2002, bringing over 20 years of experience in Research and Development, and business roles with biotechnology companies. Prior to Alnylam he served as an officer and a member of the management team for Millennium Pharmaceuticals, Inc. As Senior Vice President, Strategic Product Development for Millennium, he was responsible for the company's product franchises in Oncology, Cardiovascular, Inflammation and Metabolic Diseases. He was previously Vice President, Strategic Planning and M&A and prior to that he was General Manager of Millennium BioTherapeutics, Inc., a former subsidiary of Millennium.

Before Millennium he served as Director of Molecular Biology and Director of Market and Business Development at Biogen Idec. At Biogen, Dr. Maraganore invented and led the discovery and development of Angiomax™ (bivalirudin for injection, formerly Hirulog™) currently marketed by The Medicines Company. Prior to Biogen, Dr. Maraganore was a scientist at ZymoGenetics, Inc. and the Upjohn Company.

Dr. Maraganore received his M.S. and Ph.D. in biochemistry and molecular biology at the University of Chicago.


Edward C. Saltzman
Founder and President, Defined Health

Edward C. SaltzmanEd is founder and President of Defined Health, a leading consultancy in business development and disease area strategy for the pharmaceutical industry. Since its founding in 1983, Defined Health has completed thousands of opportunity assessments and commercial forecasts of development stage projects for hundreds of corporate clients across the Big Pharma, Biotechnology and Specialty Pharma complex. Defined Health’s length and breadth of experience in evaluating pipeline opportunities provides the firm with a unique and often unconventional spotlight on strategic issues confronting the industry, particularly with respect to the quality of the development pipeline and its implications for sustainability of established and evolving business models.

Ed is a noted speaker on industry strategy and was one of the earliest critics of the Pharma industry blockbuster business model and its over-dependence on in-licensing late-stage primary care blockbuster drugs to fuel growth. Ed was also one of the first to spot the limitation of the specialty pharma serial product acquisition model, and, as a result, he is much sought after for strategic guidance by specialty pharma and biotech companies facing sustainability challenges.

Ed began his involvement with the pharma industry at the Ayerst Laboratories unit of American Home Products, where he had responsibility for evaluation and forecasting of compounds being considered for licensing. Prior to Ayerst, he managed the Healthcare Information Center at FIND/SVP.

Ed is a member of the Licensing Executives Society and the New York Pharma Forum and is a graduate of New York University.


James B. Hunt, Jr.
Former Governor of North Carolina

Governor James B. Hunt, Jr.As Governor for four historic terms, Jim Hunt has led North Carolina through two decades of dramatic economic change. It was during his tenure as Governor that the state transitioned from an economy of primarily traditional industries toward one that includes knowledge-driven industries such as biotechnology, pharmaceuticals and information technology.

Through this change, and in large measure because of Governor Hunt’s leadership, North Carolina consistently ranked at the top of the nation in economic growth, job creation and capital investment and was nationally recognized for its top business climate. While in office, Governor Hunt focused on new-economy strategies by establishing the North Carolina School of Science and Mathematics, the Microelectronics Center of North Carolina, and the North Carolina Biotechnology Center – all of which helped solidify North Carolina’s reputation as the most innovative state in the nation in information technology and biotechnology.

Top business leaders from around the country have called former North Carolina Governor Jim Hunt a national pioneer in education and economic reform.  His work in the areas of education and economic growth have garnered him numerous awards, including the “Excellence in Public Policy Award” from the New York-based Committee for Economic Development. Governor Hunt was also recently named one of the ten most influential people in American education, along with Microsoft Chairman Bill Gates, President George Bush and former President Bill Clinton.

Governor Hunt holds B.A. and M.S. degrees from North Carolina State University, the J.D. degree from the University of North Carolina at Chapel Hill, and honorary degrees from over a dozen colleges and universities.

Today, Governor Hunt is a member in the law firm of Womble Carlyle Sandridge & Rice, PLLC and serves as chairman of the James B. Hunt, Jr. Institute for Educational Leadership and Policy in Chapel Hill.  He also is chairman of the boards of the National Center for Public Policy and Higher Education and the Institute for Emerging Issues at North Carolina State University.  He and his wife, Carolyn, live on their beef cattle farm in eastern North Carolina.  They have four children and ten grandchildren.


Featured Panelists

Visit the Biotech 2007 Web site to see last year’s top-notch speakers.